Recognising future leaders

Date Published: 24.03.2022

Wadham DPhil student Laura Bickerton has been selected as a member of the 2022 class of CAS Future Leaders.

“I am excited for the chance to be inspired by, learn from, and engage with academic and industry leaders"

Laura Bickerton

Each year the American Chemical Society announces a group of elite PhD students and postdoctoral scholars from around the world to take part in leadership training including a trip to the ACS National Meeting and Exposition in Columbus, Ohio.

Laura (Chemistry, 2018) is one of 29 students selected to take part in this year’s programme, providing an opportunity to expand her professional networks worldwide.

Laura is currently in the final few months of her DPhil in Inorganic Chemistry working under the co-supervision of Prof Matthew Langton and Wadham Fellow, Prof Paul Beer.

“During my research I have used my synthetic organic and inorganic chemistry skills, in concert with careful design, to synthesize families of highly active and selective anion receptors, capable of facilitating the transport of biologically relevant anions across cell membranes as an unprecedented method of treatment for life-threatening disorders such as cystic fibrosis and cancer,” said Laura. Anion receptors are molecules that recognize, respond to, or sense species that carry a negative charge she explains.

“I am excited for the chance to be inspired by, learn from, and engage with academic and industry leaders whilst connecting with fellow young researchers on the CAS Future Leaders program. Once I have completed my DPhil here at Wadham, I will be moving to the University of Edinburgh for a post-doctoral position with Dr Paul Lusby working on catalysis in molecular capsules.”

Related links

More about the CAS future leaders programme

CAS names its 2022 Future Leaders (

More about Laura Bickerton

More like this

View all

Bioprinting to aid drug development

New bioprinting research from Wadham’s Alfonso Castrejón-Pita will allow scientists to recreate complex biological scenarios, such as niches where cancer grows, to study disease and develop drugs.

Find out more

Mark Thompson: Affordable prostheses bring employment hope to Indian amputees

Impacting affordable healthcare in India.

Find out more